Literature DB >> 26320880

Trials are best, ignore the rest: safety and efficacy of digoxin.

Graham D Cole1, Darrel P Francis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26320880     DOI： 10.1136/bmj.h4662

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Digoxin and mortality: lessons for observational studies.

Authors:  Anthonius de Boer; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2015-11-20       Impact factor: 4.335

2.  Observational research rigour alone does not justify causal inference.

Authors:  Keisuke Ejima; Peng Li; Daniel L Smith; Tim R Nagy; Inga Kadish; Thomas van Groen; John A Dawson; Yongbin Yang; Amit Patki; David B Allison
Journal:  Eur J Clin Invest       Date:  2016-10-28       Impact factor: 4.686

Review 3.  A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population.

Authors:  Mariam H Abdel Jalil; Noura Abdullah; Mervat M Alsous; Mohammad Saleh; Khawla Abu-Hammour
Journal:  Br J Clin Pharmacol       Date:  2020-04-01       Impact factor: 4.335

Review 4.  The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets.

Authors:  Sameer Zaman; Saman S Zaman; Timothy Scholtes; Matthew J Shun-Shin; Carla M Plymen; Darrel P Francis; Graham D Cole
Journal:  Eur J Heart Fail       Date:  2017-06-08       Impact factor: 15.534
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.